文献速递艾滋病与性传播感染

印度一线治疗失败女性血液与生殖道HIV-1耐药高度不一致

High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

在印度金奈YRG艾滋病研究与教育中心,对一线抗逆转录病毒治疗至少6个月的女性检测血浆病毒载量(PVL)和生殖道病毒载量(GVL)及耐药。200名女性中37%可检测到PVL,其中74%PVL>2000 copies/mL,这些女性中74%可检测到GVL。仅10%女性三个腔室耐药完全一致,生殖道或原病毒与血浆不一致的突变分别导致24%和30%的临床相关耐药。

要点

  • 200名一线治疗至少6个月的印度女性中37%可检测到PVL(>400 copies/mL)。
  • PVL>2000 copies/mL的女性中74%可检测到GVL,PVL越高GVL越高。
  • 仅10%女性血浆、生殖道、原病毒三腔室耐药完全一致。

核心结论

  • 印度女性中鉴定出高耐药率和高腔室间耐药不一致,可能导致未被识别的耐药传播和再出现,损害治疗结局。

研究设计与样本

  • 在印度金奈YRG艾滋病研究与教育中心,对一线ART至少6个月的女性检测PVL、GVL及血浆、生殖道、原病毒逆转录酶耐药。
  • 采用Wilcoxon秩和检验和Fisher精确检验识别失败与耐药关联,Pearson相关评估PVL-GVL关联,广义估计方程评估腔室间耐药不一致。

主要发现

  • 200名女性中37%可检测到PVL(>400 copies/mL),31%PVL>1000 copies/mL。
  • 可检测到PVL的女性中74%PVL>2000 copies/mL,其中74%可检测到GVL。
  • 21名女性有配对血浆和生殖道序列,平均年龄34岁,中位ART时长33个月,中位CD4计数217 cells/mm3,中位PVL 5.4 log10 copies/mL,中位GVL 4.6 log10 copies/mL。
  • 81%-91%样本检测到耐药,67%-76%样本存在双类耐药。
  • 仅10%女性三个腔室耐药完全一致;生殖道-原病毒不一致显著大于血浆-原病毒不一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Examine HIV-1 plasma viral load (PVL) and genital tract (GT) viral load (GVL) and drug resistance in India. METHODS: At the YRG Centre for AIDS Research and Education, Chennai, we tested: PVL in women on first-line ART for ≥6 months; GVL when PVL >2000 copies/mL; and plasma, genital and proviral reverse transcriptase drug resistance when GVL >2000 copies/mL. Wilcoxon rank-sum and Fisher's exact tests were used to identify failure and resistance associations. Pearson correlations were calculated to evaluate PVL-GVL associations. Inter-compartmental resistance discordance was evaluated using generalized estimating equations. RESULTS: Of 200 women, 37% had detectable (>400 copies/mL) PVL and 31% had PVL >1000 copies/mL. Of women with detectable PVL, 74% had PVL >2000 copies/mL, of which 74% had detectable GVL. Higher PVL was associated with higher GVL. Paired plasma and genital sequences were available for 21 women; mean age of 34 years, median ART duration of 33 months, median CD4 count of 217 cells/mm3, median PVL of 5.4 log10 copies/mL and median GVL of 4.6 log10 copies/mL. Drug resistance was detected in 81%-91% of samples and 67%-76% of samples had dual-class resistance. Complete three-compartment concordance was seen in only 10% of women. GT-proviral discordance was significantly larger than plasma-proviral discordance. GT or proviral mutations discordant from plasma led to clinically relevant resistance in 24% and 30%, respectively. CONCLUSIONS: We identified high resistance and high inter-compartmental resistance discordance in Indian women, which might lead to unrecognized resistance transmission and re-emergence compromising treatment outcomes, particularly relevant to countries like India, where sexual HIV transmission is predominant.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Saravanan S, Gomathi S, Delong A, et al. High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy. J Antimicrob Chemother. 2018. PMID: 29800305. doi:10.1093/jac/dky154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。